Sponsor or institution
Clinical trials and research at National Cancer Center Hospital East
As of November 12, 2026, Find a Trial lists 4 clinical trials run by National Cancer Center Hospital East that are recruiting, in Japan. By phase: Phase 3 (2), Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Nivolumab for recurrent or metastatic olfactory neuroblastoma | Phase 2 | Kashiwa, Chiba and 1 other locations | Recruiting | Aug 3, 2025 |
| Neoadjuvant pembrolizumab with FLOT chemotherapy and short-course radiation for locally advanced gastroesophageal junction cancer | Phase 2 | Kashiwa, Chiba | Recruiting | Jun 12, 2025 |
| Comparing two treatment approaches for locally advanced rectal cancer | Phase 3 | Chiba and 33 other locations | Recruiting | Dec 12, 2022 |
| Comparing surgery plus chemotherapy to chemoradiotherapy followed by surgery plus chemotherapy for recurrent rectal cancer | Phase 3 | Chiba and 44 other locations | Recruiting | Feb 28, 2020 |
All recruiting trials (4)
-
Nivolumab for recurrent or metastatic olfactory neuroblastoma
This trial will try nivolumab, a PD‑1 immunotherapy, in adults with recurrent or metastatic olfactory neuroblastoma to see if it controls tumor growth and is safe.
-
Neoadjuvant pembrolizumab with FLOT chemotherapy and short-course radiation for locally advanced gastroesophageal junction cancer
This treatment plan will test whether pembrolizumab plus FLOT chemotherapy given before and after a short course of radiation can let some patients with locally advanced gastroesophageal junction adenocarcinoma avoid surgery or improve cancer control.
-
Comparing two treatment approaches for locally advanced rectal cancer
This study is testing if a new combination of radiation and chemotherapy can help people with locally advanced rectal cancer respond better to treatment and possibly avoid major surgery.
-
Comparing surgery plus chemotherapy to chemoradiotherapy followed by surgery plus chemotherapy for recurrent rectal cancer
This study is testing if giving patients with recurrent rectal cancer a combination of radiation and chemotherapy before surgery can help them live longer without the cancer coming back compared to just having surgery followed by chemotherapy.
Quick answers
How many clinical trials run by National Cancer Center Hospital East are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in Japan. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2, Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.